Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS
· Delayed Price · Currency is USD
27.73
+0.80 (2.97%)
At close: May 20, 2025
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $5.95 billion as of July 3, 2025. Its market cap has increased by 7.78% in one year.
Market Cap
5.95B
Enterprise Value
7.15B
Revenue
3.13B
Ranking
n/a
PE Ratio
16.58
Stock Price
$27.73
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.95B, an increase of 613.71%. That is a compound annual growth rate of 10.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.63B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 640.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 541.69M |
| American Oncology Network | 443.39M |
| Northwest Biotherapeutics | 363.62M |